Meet the Editorial Team
Immaculata De Vivo, MPH, PhD, is Professor of medicine at Harvard Medical School and of epidemiology at the Harvard T.H. Chan School for Public Health, and Co-Director for Science at the Radcliffe Institute for Advanced Study, Harvard University.
Emma H. Allott, PhD, is a Lecturer in Molecular Cancer Epidemiology at Queen’s University Belfast, Northern Ireland and an Adjunct Assistant Professor in the Trinity Translational Medicine Institute at Trinity College Dublin, Ireland. Her research integrates epidemiologic methods and design with molecular tumour profiling to identify mechanisms linking dietary and lifestyle factors with cancer risk and progression. Her current work utilizes imaging, metabolomics, and genomics data to study the role of obesity and metabolic health in prostate cancer outcomes, molecular histopathology approaches to characterize the tumour microenvironment, and molecular epidemiology studies with genomic profiling of archival tissue samples to examine the effect of statin use and dysregulated tumour lipid metabolism on lethal prostate cancer risk.
Kimberly Bertrand, ScD, is Assistant Professor at the Boston University School of Medicine and Epidemiologist at the Slone Epidemiology Center at Boston University. Dr. Bertrand’s current research efforts focus on understanding racial disparities in cancer incidence and outcomes, primarily for breast cancer. Other areas of research interest include the epidemiology of non-Hodgkin lymphoma and multiple myeloma. The majority of her research to date has been based in large, well-established cohorts and has focused on modifiable lifestyle risk factors. She also has experience in the analysis of geospatial-based exposures in relation to cancer as well as biomarker-based epidemiologic studies.
Brenda Birmann, ScD, is Assistant Professor at Harvard Medical School and Associate Epidemiologist at Brigham and Women's Hospital. Her research focuses on the epidemiology of hematopoietic malignancies, oncogenic virus infections, and the assessment of immune dysfunction for epidemiologic studies. Her primary active research projects are prospective evaluations of lifestyle correlates of energy balance (anthropometric measures, physical activity, diet) and other environmental risk factors, as well as biomarkers of growth factor, cytokine and other endogenous hormone dysregulation, in the etiology and survival of multiple myeloma and lymphoma.
Theodore M. Brasky, PhD, is an Assistant Professor and Cancer Epidemiologist at The Ohio State University College of Medicine. Dr. Brasky has several research interests, including the relation of diet, dietary supplements, and medications with cancer risk and progression. Dr. Brasky has a secondary interest in tobacco cessation and use of novel tobacco products in cancer patients.
Jennifer Cameron, PhD, is an Assistant Professor in the Department of Microbiology, Immunology & Parasitology at Louisiana State University Health Sciences Center in New Orleans. Dr. Cameron is a tumor virologist specializing in human papillomavirus (HPV) and Epstein-Barr virus (EBV) associated cancers. Cancer is a relatively rare occurrence following infection with these extremely common viruses, suggesting that hereditary, immunologic, environmental, and/or socio-behavioral factors cooperate with tumor viruses to promote cancer development. Dr. Cameron’s research focuses on identifying the underlying factors that contribute to HPV-associated cancer development, including dissecting potential synergistic effects of HPV and EBV inhabiting the same tissue microenvironment. These findings can be leveraged to design sophisticated cancer screening approaches that incorporate personalized risk assessment, resulting in targeted intervention for those HPV infected patients at highest risk. The work may also reveal novel intervention strategies that interrupt pro-carcinogenic processes and prevent cancer development. Dr. Cameron is also interested in research to predict the long-term impact of the HPV vaccine in a variety of at-risk populations and public health initiatives to improve vaccine uptake.
Eunyoung Cho, ScD, is Associate Professor of Dermatology and Epidemiology at Brown University. Dr. Cho’s primary research interest is evaluating the role of diet and nutrition in relation to the development of chronic diseases using epidemiologic approach. Dr. Cho’s current research largely focuses on diet and nutrition in relation to skin cancer and other dermatological disorders including alopecia areata, psoriasis, atopic dermatitis, and rosacea. She has also led several projects on age-related macular degeneration, colorectal cancer, breast cancer, and kidney cancer.
Marta Crous Bou, PhD, is a Principal Investigator at the Barcelonaβeta Brain Research Center. Her expertise areas are molecular epidemiology, risk factors, genetic susceptibility, environmental exposures, gene-environment interactions, biomarkers, epigenetics, carcinogenesis, and colorectal cancer.
Mengmeng Du, ScD, is an assistant member and assistant attending epidemiologist at Memorial Sloan Kettering Cancer Center. She primarily studies risk factors (inherited and modifiable) and tumor mutation profiles for colorectal, endometrial, and pancreatic cancers. Her interests also encompass cancer biomarkers, risk prediction, and surveillance. Dr. Du uses data from several large international consortia, observational studies, and clinical populations.
Holly R. Harris, ScD, MPH, is Assistant Member at the Fred Hutchinson Cancer Research Center, Seattle. Dr. Harris’s research broadly examines lifestyle, nutrition, and genetic factors and their impact on women’s health. Specifically, it is focused on ovarian and breast cancer, as well as hormonally related conditions that have shared reproductive risk factors with these diseases, including endometriosis and uterine fibroids. Her research aims to understand the role of the modifiable factors across the life course (e.g., diet and lifestyle) on the risk of these conditions using both observational cohorts and intervention studies. In addition, Dr. Harris’s research examines the interrelatedness of non-malignant and malignant conditions and their shared risk factors. In particular, focusing on understanding the endometriosis to ovarian cancer transition and identifying sub-groups of women that would most benefit from ovarian cancer screening modalities that are not currently appropriate for population-based use.
Jaime E. Hart, ScD, is Assistant Professor at the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School and the Department of Environmental Health at the Harvard TH Chan School of Public Health. Dr. Hart’s research focuses on the impacts of environmental exposures on chronic disease risk and on examining the impacts of multiple exposures simultaneously (e.g. the external exposome). She also has a strong emphasis on applying spatial methods and geographic information systems (GIS) to develop exposure models, map patterns of diseases and exposures, and append contextual measures to long standing prospective cohorts.
Michelle D. Holmes, MD, DrPH, is an associate professor of medicine at Harvard Medical School and an associate professor in the department of Epidemiology at Harvard School of Public Health. Her research interests include lifestyle factors (diet, weight change, physical activity, and psychosocial factors, common medications like aspirin) affecting quality of life and survival after a cancer diagnosis, as well as the association between diet and breast cancer risk. She has helped to design a collaborative longitudinal study of non-communicable disease (obesity, diabetes, high blood pressure, heart disease, cancer) at 5 sites in sub-Saharan Africa.
Corinne E Joshu, PhD, MPH, is an Associate Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health and a member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Her research interests include the role of modifiable risk factors, including obesity, in cancer incidence and survival after a cancer diagnosis. She also conducts research to identify opportunities to improve cancer prevention and treatment among the general population, as well as among potentially underserved communities, including people living with HIV and Medicaid beneficiaries. Her work is based within population-based observational cohort studies, administrative insurance claims, integrated health systems data, and information from cancer registries and vital statistics.
Seungyoun Jung, PhD, is an assistant professor at the University of Maryland School of Medicine and an epidemiologist with extensive training and research experience in nutrition and cancer epidemiology. The primary focus of Dr. Jung’s research is to elucidate the role of diet and its underlying mechanisms in relation to cancer development and progression by integrating nutrition, biomarker, epidemiology, and metabolomics in individual cohorts and international consortia. Specifically, her main research includes stratification of dietary factors by subtypes of breast cancers and colorectal cancers, identification of early-life dietary factors and diet-related physiologic mechanisms for the early development of breast cancer, and the examination of diet’s role in quality of life and health disparity among breast cancer survivors.
Elizabeth D. Kantor, PhD, is an Assistant Member at Memorial Sloan Kettering Cancer Center. Her research centers on understanding how modifiable exposures, such as drugs and supplements, relate to cancer risk and survival. Dr. Kantor seeks to address these research interests through use of data from a variety of sources, including a number of epidemiologic cohorts, nationally representative surveys, and integrated healthcare delivery systems.
Jaya Khushalani, PhD, MD, MHA, is a Health Policy Scientist at the Office of the Associate Director for Policy and Strategy at the Centers for Disease Control and Prevention. Dr. Jaya’s research focuses on policy and economic analyses of topics related to cancer, mental health, and opioid use. Her interests lie in cancer disparities, primary prevention of cancer, and economic burden of cancer survivorship. She has experience conducting econometric analysis and decision modelling using multiple secondary data sources such as claims data, survey data, and cancer registry data.
Pagona Lagiou, MD, MSc, PhD, is Chair of the Department of Hygiene, Epidemiology and Medical Statistics at the School of Medicine, National and Kapodistrian University of Athens, Greece. She serves as Professor of Hygiene and Epidemiology at the same Department and as Adjunct Professor of Epidemiology at the Harvard T.H. Chan School of Public Health. Dr. Lagiou has served as Foreign Adjunct Associate Professor of Epidemiology at the Karolinska Institutet, Sweden, as well as a panel member at the European Food Safety Authority and the European Research Council. She is Head of the WHO Collaborating Center for Nutrition and Health in Athens, Greece and her research interests include the nutritional and endocrine epidemiology and etiology of cancer, cardiovascular diseases, and other chronic conditions.
Faina Linkov, MPH, PhD, is a Department Chair and Associate Professor at Duquesne University. She is a multidisciplinary researcher with research interests in molecular epidemiology, cancer, prevention, health systems research, global health, scientific communications, and research productivity. In the area of molecular epidemiology, her work focuses on the use of biological tumor markers to detect malignancies at early stages and on the link between obesity, biobehavioral factors, and cancer. Dr. Linkov's longitudinal investigations have made significant contributions to the emerging view that intentional weight loss may play a significant role in the prevention of malignancies and normalization of aging associated biomarkers, especially through inflammatory pathways.
Jason Liu, ScD, MS, MPH, is an Assistant Professor at National Yang-Ming University's Institute of Public Health in Taipei, Taiwan. His research interests include cancer incidence and mortality trends, cancer survivors' health, as well as biomarkers and other predictors of cancer risk. He is studying the incidence rates of childhood, adolescent, and young adulthood cancers in Taiwan, and the associations between these cancers and subsequent health outcomes.
Erin L. Marcotte, MPH, PhD, is an Assistant Professor in the Division of Epidemiology and Clinical Research in the Department of Pediatrics at the University of Minnesota. She works in collaboration with colleagues nationally and internationally through the Children's Oncology Group and the Childhood Cancer and Leukemia International Consortium (CLIC). Dr. Marcotte’s primary research is focused on the genetic, molecular, and environmental causes of childhood leukemia and hepatoblastoma. She is also interested in understanding how maternal and early life nutrition impact childhood cancer risk. Finally, she has several ongoing projects which aim to understand cancer risk among individuals with neurofibromatosis type I.
Sarah Markt, ScD, MPH is Assistant Professor in the Department of Population and Quantitative Health Sciences at the Case Western Reserve University School of Medicine. Dr. Markt’s research integrates molecular, lifestyle, and clinical epidemiology to study risk factors for initiation and progression of cancer, with the primary goal to translate research findings into direct application for primary and secondary cancer prevention. Her work has utilized data from large population based cohorts from the United States, Sweden, Iceland, and Finland, and clinical cohorts from electronic health record data. Her research is primarily focused on understanding the role of modifiable lifestyle factors (sleep, weight, physical activity) and genomic tumor biomarkers in prostate, bladder and testicular cancer risk and progression.
Dominique Michaud, ScD, is a Professor at Tufts University School of Medicine. Her research is mainly focused on better understanding the causes of pancreatic and brain cancers with the goal of providing means to prevent these deadly cancers. Dr. Michaud works primarily with large cohort studies and examines risk factors such as diet, BMI, allergies, infection, and genetic susceptibility.
Alison M. Mondul, PhD, MSPH, is an Assistant Professor in the Department of Epidemiology at the University of Michigan School of Public Health. Dr. Mondul studies the role of modifiable risk factors in the etiology of cancer. In particular,she studies how lifestyle factors (such as use of common medications) and factors related to diet and nutrition (such as micronutrients and lipids) may influence prostate and head and neck cancers, as well as benign prostatic hyperplasia. In order to study these associations Dr. Mondul employs molecular epidemiologic techniques including hypothesis-driven studies of serum biomarkers, genome-wide association studies, and metabolomic profiling.
Hazel B. Nichols, PhD, is an Associate Professor of epidemiology at the University of North Carolina (UNC) Gillings School of Global Public Health and a member of the UNC Lineberger Comprehensive Cancer Center. Her research is focused on improving cancer care by providing epidemiologic evidence to guide personal and medical decision-making around cancer risk and survivorship. Her research addresses the intersection of cancer and pregnancy across the lifespan; and health outcomes and survivorship after an endometrial, breast, or adolescent or young adult cancer diagnosis. Her work is based within population-based observational cohort studies, cohorts identified in health systems data, and uses linked information from cancer registries, vital statistics, healthcare databases, and administrative insurance claims.
Jessica Petrick, PhD, MPH, is an Assistant Professor at the Boston University School of Medicine and Epidemiologist at the Slone Epidemiology Center at Boston University. Dr. Petrick’s research focuses on the epidemiology of gastrointestinal cancers, including colorectal, liver, and esophageal. The emphasis of her current research is on nutritional and molecular factors, including the metabolome and microbiome, which may contribute to health disparities along the cancer continuum—from precursor lesions to invasive cancer through mortality.
Camille Ragin, PhD, MPH, is Professor in the Cancer Prevention and Control Program at Fox Chase Cancer Center-Temple University Health System. Dr. Ragin’s research efforts focus on cancer epidemiology and prevention primarily in Black populations. Her areas of research involve investigations of the influence of culture and genetic ancestry on health, cancer development, survivorship, health disparities, and immigrant health She has forged collaborations nationally and internationally with highly esteemed researchers to examine disparities in prostate, cervical, breast, head and neck, and lung cancers.
Sabine Rohrmann, MPH, PhD, is Head of the Cancer Registry of the cantons Zurich, Zug, Schaffhausen, and Schwyz in Switzerland and an adjunct professor of the University of Zurich. Dr. Rohrmann is interested in cancer epidemiology, with a focus on diet and lifestyle as risk factors for cancer and on the use of cancer registry data.
Eva Schernhammer, MD, is an Associate Professor at Harvard Medical School. Her research focuses on the influence of lifestyle as well as gene-environment interactions in the context of chronic diseases. These include a variety of cancers such as breast, colon, and pancreatic cancer, cardiovascular disease and diabetes, as well as neurodegenerative diseases including Parkinson’s disease and its relation with cancer etiology, to further understand biological mechanisms in carcinogenesis.
Lisa B. Signorello, ScD, is the Director of the Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute. She has experience with community-based, hospital-based, and population-based epidemiologic studies that focus on cancer incidence and mortality. Her research focuses on cancer etiology and cancer prevention for adult solid tumors, including an array of factors (sociodemographic, behavioral/lifestyle, environmental, pharmacologic, infectious, genetic, and health care-related) that may contribute to cancer disparities. She has expertise with survey-based, biomarker-based, and registry-based research studies. She also conducts both qualitative and quantitative studies to generate evidence to improve the training and development of the cancer research workforce.
Siobhan Sutcliffe, PhD, is a Professor at the Washington University School of Medicine. She is an epidemiologist whose longstanding research interests are infectious causes of cancer and chronic diseases. Her research to date has focused on infectious or inflammatory causes of prostate cancer and benign prostatic hyperplasia (BPH), including studies on the possible roles of gonorrhea, syphilis, Chlamydia trachomatis infection, Trichomonas vaginalisinfection, human papillomavirus infection, human herpesvirus type 8 infection, and several other viral infections in prostate cancer and/or BPH development.
Fred K. Tabung, PhD, MSPH, is an Assistant Professor at The Ohio State University College of Medicine and Comprehensive Cancer Center. Dr. Tabung’s research involves the role of dietary patterns and lifestyle factors in cancer risk and treatment response, specifically among patients with gastrointestinal tract cancers. This work is conducted mainly through the integration of novel dietary patterns, biomarkers, metabolomics, and gut microbiome data to comprehensively investigate and identify potential biological pathways linking dietary patterns and cancer risk and survival. An important aspect of Dr. Tabung’s research effort is the translation of research findings from large epidemiological cohorts into the clinical setting using randomized dietary intervention trials, to determine dietary patterns for healthy eating and develop therapeutic diets.
Kathryn Terry, ScD, is an Associate Professor at Harvard Medical School. She is interested in how genetic variation and environmental exposures influence ovarian cancer risk and survival. In particular, her research focuses on how risk may vary by subtypes of ovarian cancer which may be defined by histologic subtype, cell or origin, or etiologic pathway.
Britton Trabert, PhD, MS, is Earl Stadtman Investigator at the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, NIH, DHHS. Dr. Trabert’s research focuses on the hormonal etiology of female cancers and the epidemiology and etiologic heterogeneity of ovarian and endometrial cancers. Specifically, she has focused on clarifying the role of both systemic and local inflammation in ovarian and endometrial carcinogenesis. Dr. Trabert has contributed significantly to improving the scientific understanding of the relationship between exogenous hormone use and endogenous hormone levels and female cancer risk. Dr. Trabert’s diverse research portfolio has included methodologic validation of hormone assays and evaluation of cancer trends using US and international cancer registries as well as the evaluation of cancer risk factors in large population-based case-control and cohort studies and in international consortia. She also has considerable expertise leading molecular epidemiologic studies.
Lusine Yaghjyan, MD, PhD, is an Assistant Professor and an Epidemiologist at the University of Florida College of Public Health and Health Professions and College of Medicine. Dr. Yaghjayn’s research primarily focuses on etiology and molecular epidemiology of breast cancer, benign breast disease, and high mammographic breast density. She has been working with several well-established cohorts to examine associations of various factors early in life and in adulthood with these outcomes. Dr. Yaghjyan currently focuses on emerging areas in breast cancer research, such as potential application of breast stem cell markers for risk prediction in women with benign breast biopsies and contributions of gut microbiota to breast carcinogenesis. Other areas of her research include the role of environmental risk factors, such as endocrine disruptors and air pollution, in breast cancer etiology.
Xuehong Zhang, ScD, is Assistant Professor at the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School and the Department of Nutrition at the Harvard TH Chan School of Public Health. Dr. Xuehong Zhang is a cancer epidemiologist with training in clinical medicine and nutrition. He has extensive experience in conducting cohort and international consortia. He integrates epidemiology, lifestyle, environmental factors, and –omic techniques to conduct multidisciplinary investigations. The overall theme of his research program is to identify dietary, lifestyle, genetic, and biological determinants of cancer and determine whether these factors inform early detection and diagnosis, as well as survival among cancer survivors. He mainly studies gastrointestinal cancers, especially colorectal cancer and liver cancer.